414 related articles for article (PubMed ID: 29414252)
1. Heart Failure with Preserved Ejection Fraction.
Gladden JD; Chaanine AH; Redfield MM
Annu Rev Med; 2018 Jan; 69():65-79. PubMed ID: 29414252
[TBL] [Abstract][Full Text] [Related]
2. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
3. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
4. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
Tannenbaum S; Sayer GT
Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
[TBL] [Abstract][Full Text] [Related]
5. Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.
Lekavich CL; Barksdale DJ; Neelon V; Wu JR
Heart Fail Rev; 2015 Nov; 20(6):643-53. PubMed ID: 26404098
[TBL] [Abstract][Full Text] [Related]
6. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Heart; 2019 Aug; 105(16):1252-1259. PubMed ID: 30792238
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Raj L; Adhyaru B
Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
[TBL] [Abstract][Full Text] [Related]
9. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
Kjeldsen SE; von Lueder TG; Smiseth OA; Wachtell K; Mistry N; Westheim AS; Hopper I; Julius S; Pitt B; Reid CM; Devereux RB; Zannad F
Hypertension; 2020 Jan; 75(1):23-32. PubMed ID: 31786973
[TBL] [Abstract][Full Text] [Related]
10. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.
Pugliese NR; Masi S; Taddei S
Heart Fail Rev; 2020 Jan; 25(1):31-42. PubMed ID: 31512149
[TBL] [Abstract][Full Text] [Related]
12. Current challenges in the management of heart failure.
Komajda M
Circ J; 2015; 79(5):948-53. PubMed ID: 25877621
[TBL] [Abstract][Full Text] [Related]
13. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
From AM; Borlaug BA
Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
[TBL] [Abstract][Full Text] [Related]
14. Heart Failure Guidelines on Pharmacotherapy.
Papadimitriou L; Hamo CE; Butler J
Handb Exp Pharmacol; 2017; 243():109-129. PubMed ID: 28451824
[TBL] [Abstract][Full Text] [Related]
15. Heart failure with preserved ejection fraction: a clinical dilemma.
Komajda M; Lam CS
Eur Heart J; 2014 Apr; 35(16):1022-32. PubMed ID: 24618346
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Heart Failure with Preserved Ejection Fraction.
Ilieșiu AM; Hodorogea AS
Adv Exp Med Biol; 2018; 1067():67-87. PubMed ID: 29498023
[TBL] [Abstract][Full Text] [Related]
19. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
[TBL] [Abstract][Full Text] [Related]
20. MY APPROACH to heart failure with preserved ejection fraction.
Borlaug BA
Trends Cardiovasc Med; 2014 Nov; 24(8):369-70. PubMed ID: 25267507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
